NCT00019136View on ClinicalTrials.gov

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1997

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

MOv-gamma chimeric receptor gene

BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic allogeneic lymphocytes

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019136 - Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter